Kenvue, Fortrea Draw Options Attention Into Earnings Week

Earnings season and a looming index shake-up are pushing options activity into names that rarely top the flow tables.

KVUE faces the sharpest structural pressure. ORTEX Index Rebalance Radar puts a 93% probability on Kimberly-Clark's acquisition closing between November and December. That would force KVUE out of the S&P 500, the Russell 1000 and the Russell 3000. Total forced selling across all three indices is estimated at $1.8bn. The S&P 500 removal alone equals 3.4 days of normal volume. An index announcement is expected around 20 November. Options traders positioning ahead of that window face a hard deadline and a known direction.

FTRE is a different story. Short interest has reached a one-year high ahead of Sunday's Q3 print. The ORTEX short score sits at 60.5. Days to cover stand at 3.9. Analysts have a negative return potential of 9.8% on the stock. The RSI at 75 suggests the recent price run has outpaced fundamentals. That combination, high short interest plus an overbought signal plus a looming earnings date, is where put volume tends to cluster.

SPFI stands out on the bullish side. ORTEX flagged options leaning positive ahead of today's Q3 report, with unresolved insider sales adding uncertainty to the read.

Semiconductors dominate positive options bets by dollar value. MU and NVDA top the list, with AMD and INTC close behind. Taiwan's export orders hit a record $114.2bn in September, the largest September total since 1984 according to ORTEX Alt Data. That backdrop supports demand assumptions for memory and logic chips. Options flow in that group is leaning bullish.

The week closes with 10x Genomics caught between a Russell 2000 deletion and Russell 1000 addition, with a 4.9% daily volatility making the outcome genuinely open. A confirmed Russell 1000 inclusion would force $443m of buying.